Ketipine (Quetiapine)

Quetiapine blocks several neurotransmitter receptors, especially serotonin 5‑HT2A and dopamine D2, while also antagonising histamine H1 and adrenergic α1 receptors. This multi‑receptor activity balances dopaminergic and serotonergic signaling, reducing psychotic symptoms, stabilising mood, and enhancing antidepressant effects.

The appropriate dose of Ketipine is determined individually by a qualified prescriber based on the patient’s diagnosis, severity, response, and tolerability. Dosage may be adjusted over time, and patients should follow the specific instructions provided by their healthcare professional.

Safety data for quetiapine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their physician.

To request Ketipine, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature requirements), and necessary import documentation.

Ketipine (quetiapine) shares the broad receptor‑blocking profile of atypical antipsychotics but is distinguished by a relatively lower propensity for extrapyramidal symptoms and a pronounced sedative effect due to histamine H1 antagonism. Compared with agents such as risperidone, quetiapine often requires higher doses for equivalent antipsychotic efficacy but may be preferred when sedation or mood‑stabilising properties are desired.

Ketipine should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from excess moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Ketipine is taken orally, usually as whole tablets swallowed with water. It can be taken with or without food, but patients should follow the timing and any specific instructions given by their prescriber to optimise absorption and minimise side effects.

Serious risks include neuroleptic malignant syndrome, severe neutropenia or agranulocytosis, QT interval prolongation that may lead to arrhythmias, and metabolic disturbances such as hyperglycaemia or new‑onset diabetes. Patients should be monitored regularly for these conditions, and any sudden changes in health should be reported promptly.

Ketipine is contraindicated in individuals with known hypersensitivity to quetiapine or any of its excipients. Caution is advised for patients with a history of cardiac arrhythmias, uncontrolled diabetes, severe hepatic impairment, or those taking other medications that significantly prolong the QT interval.